Impact of Genetic Risk Factors on Stroke and Dementia

Atrial Fibrillation and Its Role in Stroke Risk

Atrial fibrillation (AF) is a common cardiac arrhythmia characterized by rapid and irregular beating of the heart. It has been identified as a major risk factor for stroke, increasing the risk by up to five times compared to individuals without AF (Rydén et al., 2023). The mechanism behind this increased risk is primarily attributed to the formation of blood clots in the heart, which can travel to the brain and cause an ischemic stroke.

Research indicates that individuals with higher genetic risk for AF, as assessed through polygenic risk scores (PRS), exhibit a significantly elevated risk of experiencing both stroke and dementia. For instance, individuals in the highest tertile of AF-PRS have a 1.5-fold increased risk of developing dementia and a comparable increase in stroke risk (Rydén et al., 2023). This genetic link highlights the importance of genetic screening and management strategies in patients with AF, aiming to mitigate the risk of subsequent cerebrovascular events.

Table 1: Genetic Risk and Stroke/Dementia Associations

Heart Failure as a Contributor to Dementia Development

Heart failure (HF) is another critical factor associated with an increased risk of dementia. It is characterized by the heart’s inability to pump blood effectively, leading to reduced blood flow to various organs, including the brain. This condition not only raises the risk of stroke but also has been linked to cognitive decline and dementia (Adelborg et al., 2017; Rydén et al., 2023).

Studies have shown that individuals with higher genetic risk for HF also have a heightened risk of developing dementia, even when accounting for comorbid conditions such as AF. The mechanisms through which HF contributes to dementia include impaired cerebral blood flow, neuroinflammation, and the effects of systemic hypoxia on brain health (Qiu et al., 2006). Genetic risk assessment for HF, similar to AF, can provide valuable insights into individual risks and help guide therapeutic interventions to prevent cognitive decline.

Polygenic Risk Scores: A New Method to Assess Risk

Polygenic risk scores represent a powerful approach to assess an individual’s genetic predisposition to various diseases, including stroke and dementia. These scores are calculated based on the cumulative effect of multiple genetic variants associated with the conditions of interest. Recent research has demonstrated that higher PRS for both AF and HF correlates with an increased likelihood of developing stroke and dementia (Rydén et al., 2023).

The use of PRS allows for a more nuanced understanding of an individual’s risk profile, enabling healthcare providers to tailor prevention strategies accordingly. For example, individuals identified as being at high genetic risk for AF could benefit from more intensive monitoring and interventions aimed at reducing AF-related stroke risks, such as anticoagulant therapy.

Table 2: Polygenic Risk Scores and Associated Risks

Importance of Early Detection in Stroke and Dementia

The significance of early detection in managing stroke and dementia cannot be overstated. Early identification of individuals at high risk, particularly those with genetic predispositions, can lead to timely interventions that may prevent or delay the onset of these conditions. For example, regular monitoring and management of AF can significantly reduce stroke incidence through the use of anticoagulants (Hindricks et al., 2021).

Moreover, as the relationship between stroke and subsequent dementia becomes clearer, early stroke interventions and rehabilitation strategies can mitigate cognitive decline post-stroke. Thus, integrating genetic risk assessments into regular health screenings for older adults can facilitate preventive measures and improve long-term outcomes for at-risk populations.

Strategies for Preventing Stroke and Dementia Risks

Preventive strategies for reducing the risks of stroke and dementia include a multifaceted approach:

1. Lifestyle Modifications: Promoting a healthy lifestyle through regular exercise, a balanced diet, and smoking cessation can mitigate risk factors for both AF and HF.

2. Regular Health Screenings: Implementing routine cardiovascular health checks, including blood pressure and cholesterol monitoring, can aid in the early detection of AF and HF.

3. Genetic Risk Assessment: Utilizing polygenic risk scores for assessing individual genetic predispositions allows for personalized health strategies and targeted interventions.

4. Medication Management: For individuals with diagnosed AF or HF, adherence to prescribed medications, such as anticoagulants or heart failure medications, is crucial in reducing the risks of stroke and cognitive decline.

5. Cognitive Engagement: Encouraging activities that stimulate cognitive function can be beneficial in maintaining brain health and potentially delaying the onset of dementia.

Table 3: Preventive Strategies for Stroke and Dementia

FAQ

What is the link between atrial fibrillation and stroke?

Atrial fibrillation increases the risk of stroke by promoting blood clots in the heart, which can dislodge and travel to the brain, causing ischemic strokes.

How does heart failure contribute to dementia?

Heart failure can impair blood flow to the brain, leading to neuroinflammation and reduced oxygen supply, which may contribute to cognitive decline and increase the risk of dementi

What are polygenic risk scores?

Polygenic risk scores are calculated based on multiple genetic variants associated with a particular condition, providing a cumulative measure of genetic risk for diseases such as stroke and dementi

Why is early detection important?

Early detection of conditions like AF and HF allows for timely interventions that can significantly reduce the risk of stroke and associated cognitive decline, improving overall patient outcomes.

What preventive measures can reduce stroke and dementia risks?

Preventive measures include lifestyle modifications, regular health screenings, genetic risk assessments, medication management, and cognitive engagement activities.

References

1. Rydén, L., Seidu, N. M., Wetterberg, H., Najar, J., Waern, M., Kern, S., Zetterberg, H., & Skoog, I. (2025). Polygenic risk scores for atrial fibrillation and heart failure and the risk of stroke and dementia. Brain Communications, 6(1), fcad477
2. Adelborg, K., Szépligeti, S., Sundbøll, J., et al. (2017). Heart failure and risk of dementia: A Danish nationwide population-based cohort study. Eur J Heart Fail, 19(2), 253–260
3. Qiu, C., Winblad, B., Levälahti, E., et al. (2006). Heart diseases and long-term risk of dementia: A population-based CAIDE study. J Alzheimers Dis, 10(1), 183–191
4. Hindricks, G., Potpara, T., Dagres, N., et al. (2021). 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J, 42(5), 373–498
5. Ballas, J. A., & Howard, D. M. (1987). The perception of environmental sounds: A review. Psychological Bulletin, 101(1), 50–78
6. Coebergh, J. P., et al. (2020). Auditory agnosia for environmental sounds in Alzheimer’s disease: Effects on daily life. Journal of Clinical Medicine, 13(24), 7580. https://doi.org/10.1016/j.ibneur.2025.01.006